Rank | Gene Set | Z-score |
---|---|---|
1 | cellular potassium ion homeostasis (GO:0030007) | 6.08716424 |
2 | vocalization behavior (GO:0071625) | 5.90962160 |
3 | * membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.83204465 |
4 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.80590729 |
5 | synaptic vesicle exocytosis (GO:0016079) | 5.75238324 |
6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.64203224 |
7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.48076496 |
8 | neurotransmitter-gated ion channel clustering (GO:0072578) | 5.47678255 |
9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.47299448 |
10 | sodium ion export (GO:0071436) | 5.45591977 |
11 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.30591499 |
12 | glutamate secretion (GO:0014047) | 5.26584265 |
13 | neuronal action potential propagation (GO:0019227) | 5.17840070 |
14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.14985579 |
15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.10441218 |
16 | neuron cell-cell adhesion (GO:0007158) | 4.98073002 |
17 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.93714828 |
18 | neurotransmitter secretion (GO:0007269) | 4.84969673 |
19 | neuron-neuron synaptic transmission (GO:0007270) | 4.76601036 |
20 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.75883253 |
21 | protein localization to synapse (GO:0035418) | 4.70916550 |
22 | presynaptic membrane assembly (GO:0097105) | 4.66471745 |
23 | synaptic vesicle maturation (GO:0016188) | 4.64631267 |
24 | locomotory exploration behavior (GO:0035641) | 4.60434639 |
25 | synaptic transmission, glutamatergic (GO:0035249) | 4.59294222 |
26 | L-amino acid import (GO:0043092) | 4.55327272 |
27 | regulation of synaptic vesicle transport (GO:1902803) | 4.53285613 |
28 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.52253375 |
29 | presynaptic membrane organization (GO:0097090) | 4.41066209 |
30 | gamma-aminobutyric acid transport (GO:0015812) | 4.36558322 |
31 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.31203713 |
32 | postsynaptic membrane organization (GO:0001941) | 4.30136713 |
33 | glutamate receptor signaling pathway (GO:0007215) | 4.28572918 |
34 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.22945971 |
35 | potassium ion import (GO:0010107) | 4.20529924 |
36 | long-term synaptic potentiation (GO:0060291) | 4.16343462 |
37 | dendritic spine morphogenesis (GO:0060997) | 4.14365632 |
38 | potassium ion homeostasis (GO:0055075) | 4.10500834 |
39 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.00785805 |
40 | central nervous system myelination (GO:0022010) | 4.00778464 |
41 | axon ensheathment in central nervous system (GO:0032291) | 4.00778464 |
42 | cerebellar granule cell differentiation (GO:0021707) | 3.92104562 |
43 | response to histamine (GO:0034776) | 3.92067458 |
44 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.91433006 |
45 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.89171999 |
46 | amino acid import (GO:0043090) | 3.89146348 |
47 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.88281009 |
48 | positive regulation of dendritic spine development (GO:0060999) | 3.87965447 |
49 | positive regulation of synapse maturation (GO:0090129) | 3.83889233 |
50 | cell communication by electrical coupling (GO:0010644) | 3.83221977 |
51 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.81408565 |
52 | neurotransmitter transport (GO:0006836) | 3.81153217 |
53 | neuromuscular process controlling balance (GO:0050885) | 3.79734644 |
54 | positive regulation of membrane potential (GO:0045838) | 3.79023557 |
55 | regulation of postsynaptic membrane potential (GO:0060078) | 3.78229844 |
56 | transferrin transport (GO:0033572) | 3.77317787 |
57 | cellular sodium ion homeostasis (GO:0006883) | 3.75517383 |
58 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.74565437 |
59 | startle response (GO:0001964) | 3.72728145 |
60 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.71908865 |
61 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.71908865 |
62 | positive regulation of neurotransmitter transport (GO:0051590) | 3.70205683 |
63 | neuronal ion channel clustering (GO:0045161) | 3.69917966 |
64 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.69049028 |
65 | * membrane depolarization during action potential (GO:0086010) | 3.68133555 |
66 | exploration behavior (GO:0035640) | 3.68053039 |
67 | mechanosensory behavior (GO:0007638) | 3.64260130 |
68 | striatum development (GO:0021756) | 3.63709852 |
69 | long-term memory (GO:0007616) | 3.62909347 |
70 | regulation of synapse structural plasticity (GO:0051823) | 3.60786771 |
71 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.60483636 |
72 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.60353585 |
73 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.60002804 |
74 | regulation of synaptic plasticity (GO:0048167) | 3.59721744 |
75 | behavioral response to cocaine (GO:0048148) | 3.57897353 |
76 | * regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.57245101 |
77 | regulation of neurotransmitter levels (GO:0001505) | 3.56935112 |
78 | regulation of neurotransmitter secretion (GO:0046928) | 3.56504571 |
79 | ferric iron transport (GO:0015682) | 3.51363756 |
80 | trivalent inorganic cation transport (GO:0072512) | 3.51363756 |
81 | neurotransmitter uptake (GO:0001504) | 3.49859171 |
82 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.49335567 |
83 | neuromuscular synaptic transmission (GO:0007274) | 3.47191240 |
84 | regulation of glutamate secretion (GO:0014048) | 3.46734009 |
85 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.45800354 |
86 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.45387181 |
87 | regulation of female receptivity (GO:0045924) | 3.43737636 |
88 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.43656540 |
89 | regulation of neurotransmitter transport (GO:0051588) | 3.42894425 |
90 | neuromuscular process controlling posture (GO:0050884) | 3.42425302 |
91 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.41869163 |
92 | regulation of dendritic spine development (GO:0060998) | 3.41648171 |
93 | female mating behavior (GO:0060180) | 3.41458083 |
94 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.40882745 |
95 | layer formation in cerebral cortex (GO:0021819) | 3.39553692 |
96 | positive regulation of synaptic transmission (GO:0050806) | 3.37783306 |
97 | auditory behavior (GO:0031223) | 3.36627639 |
98 | cell differentiation in hindbrain (GO:0021533) | 3.32648212 |
99 | proline transport (GO:0015824) | 3.31136665 |
100 | transmission of nerve impulse (GO:0019226) | 3.26721429 |
101 | detection of calcium ion (GO:0005513) | 3.26682068 |
102 | behavioral defense response (GO:0002209) | 3.23907035 |
103 | behavioral fear response (GO:0001662) | 3.23907035 |
104 | regulation of synapse maturation (GO:0090128) | 3.23603652 |
105 | acidic amino acid transport (GO:0015800) | 3.22815396 |
106 | * synaptic transmission (GO:0007268) | 3.22002377 |
107 | negative regulation of dendrite development (GO:2000171) | 3.21989582 |
108 | positive regulation of synapse assembly (GO:0051965) | 3.21575762 |
109 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.19971057 |
110 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.19971057 |
111 | learning (GO:0007612) | 3.18263363 |
112 | regulation of ARF protein signal transduction (GO:0032012) | 3.17303740 |
113 | cell communication involved in cardiac conduction (GO:0086065) | 3.16748354 |
114 | synaptic vesicle endocytosis (GO:0048488) | 3.16192833 |
115 | regulation of synaptic transmission (GO:0050804) | 3.15735762 |
116 | primary amino compound metabolic process (GO:1901160) | 3.15503946 |
117 | long term synaptic depression (GO:0060292) | 3.15188601 |
118 | activation of protein kinase A activity (GO:0034199) | 3.14715446 |
119 | neuromuscular process (GO:0050905) | 3.13596291 |
120 | regulation of cell communication by electrical coupling (GO:0010649) | 3.13252896 |
121 | * membrane depolarization (GO:0051899) | 3.12890591 |
122 | membrane hyperpolarization (GO:0060081) | 3.10396795 |
123 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.10243958 |
124 | chemosensory behavior (GO:0007635) | 3.09279085 |
125 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.08986099 |
126 | response to auditory stimulus (GO:0010996) | 3.07548130 |
127 | fear response (GO:0042596) | 3.05376369 |
128 | potassium ion transmembrane transport (GO:0071805) | 3.05051662 |
129 | cellular potassium ion transport (GO:0071804) | 3.05051662 |
130 | synaptic transmission, dopaminergic (GO:0001963) | 3.03710525 |
131 | dendritic spine organization (GO:0097061) | 3.03686054 |
132 | synapse assembly (GO:0007416) | 3.01058912 |
133 | neuron recognition (GO:0008038) | 3.00746360 |
134 | serotonin metabolic process (GO:0042428) | 3.00098913 |
135 | regulation of vesicle fusion (GO:0031338) | 2.99325334 |
136 | regulation of neurotransmitter uptake (GO:0051580) | 2.96040743 |
137 | NADH metabolic process (GO:0006734) | 2.95877648 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.57320787 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.75926265 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.22375779 |
4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.09793431 |
5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.95621160 |
6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.75722594 |
7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.73053445 |
8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.64867371 |
9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.53145833 |
10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.53145833 |
11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.50044270 |
12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.48411567 |
13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.46824182 |
14 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.43992524 |
15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.42564325 |
16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.41319675 |
17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.35884441 |
18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.33102933 |
19 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.32407039 |
20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.28280629 |
21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.28251683 |
22 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.27662553 |
23 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.22932990 |
24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.12223810 |
25 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.11610568 |
26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.06263688 |
27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.02331286 |
28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.01288673 |
29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.98959843 |
30 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.96533691 |
31 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.96441328 |
32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.91238316 |
33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.90074736 |
34 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.88525925 |
35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.87352216 |
36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.79730810 |
37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.67682310 |
38 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.62054160 |
39 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.61707948 |
40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.57571781 |
41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57145680 |
42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.56080059 |
43 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.50067475 |
44 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.48213416 |
45 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.48123542 |
46 | AR_25329375_ChIP-Seq_VCAP_Human | 1.47149790 |
47 | FUS_26573619_Chip-Seq_HEK293_Human | 1.41633000 |
48 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.41570704 |
49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.41455578 |
50 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.40215430 |
51 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.39624160 |
52 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.36023588 |
53 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35817611 |
54 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.34282315 |
55 | STAT3_23295773_ChIP-Seq_U87_Human | 1.33436597 |
56 | VDR_22108803_ChIP-Seq_LS180_Human | 1.30476507 |
57 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30276011 |
58 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.30124881 |
59 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.29995710 |
60 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.27873499 |
61 | TCF4_23295773_ChIP-Seq_U87_Human | 1.26436366 |
62 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.22845953 |
63 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20168808 |
64 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.17251415 |
65 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15069740 |
66 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13520358 |
67 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.13014494 |
68 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12600093 |
69 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.12549181 |
70 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12358270 |
71 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.12074756 |
72 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.11985516 |
73 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11712759 |
74 | * AR_19668381_ChIP-Seq_PC3_Human | 1.10194015 |
75 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09927685 |
76 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.08426341 |
77 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.08111349 |
78 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07988864 |
79 | JUN_21703547_ChIP-Seq_K562_Human | 1.07742071 |
80 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06091451 |
81 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05766862 |
82 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.05104218 |
83 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05093089 |
84 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.04609070 |
85 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.04577123 |
86 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.03853080 |
87 | KDM2B_26808549_Chip-Seq_K562_Human | 1.03036898 |
88 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.03020785 |
89 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.02548958 |
90 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.02005578 |
91 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00858910 |
92 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00483960 |
93 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.98397701 |
94 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.97770986 |
95 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.97341295 |
96 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.96658618 |
97 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95360341 |
98 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.95283975 |
99 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.94868055 |
100 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.93194239 |
101 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92395652 |
102 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.91861530 |
103 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91567880 |
104 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.91567880 |
105 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.91344440 |
106 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91311432 |
107 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91106828 |
108 | KDM2B_26808549_Chip-Seq_REH_Human | 0.91022264 |
109 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.90634162 |
110 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89856955 |
111 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.89430995 |
112 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89078062 |
113 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.87951213 |
114 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.87815826 |
115 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.87662396 |
116 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.87160515 |
117 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.87047090 |
118 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.85656920 |
119 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.84903928 |
120 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82404575 |
121 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.82291887 |
122 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82284483 |
123 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.81874386 |
124 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.80698104 |
125 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80406632 |
126 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79293084 |
127 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.78331379 |
128 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77133223 |
129 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.76309247 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.60122498 |
2 | MP0003880_abnormal_central_pattern | 5.15200414 |
3 | MP0003635_abnormal_synaptic_transmissio | 4.12456799 |
4 | MP0009046_muscle_twitch | 3.92460518 |
5 | * MP0009745_abnormal_behavioral_response | 3.68606518 |
6 | MP0002822_catalepsy | 3.66881218 |
7 | * MP0002064_seizures | 3.45602561 |
8 | MP0002063_abnormal_learning/memory/cond | 3.34481929 |
9 | MP0001968_abnormal_touch/_nociception | 3.30191700 |
10 | MP0004270_analgesia | 3.15327283 |
11 | MP0002572_abnormal_emotion/affect_behav | 3.02212697 |
12 | MP0002736_abnormal_nociception_after | 2.89875235 |
13 | * MP0002272_abnormal_nervous_system | 2.80598927 |
14 | MP0001501_abnormal_sleep_pattern | 2.60397319 |
15 | MP0002734_abnormal_mechanical_nocicepti | 2.55076322 |
16 | MP0001486_abnormal_startle_reflex | 2.52209177 |
17 | MP0002735_abnormal_chemical_nociception | 2.39672000 |
18 | MP0003787_abnormal_imprinting | 2.33662946 |
19 | MP0005646_abnormal_pituitary_gland | 2.31481106 |
20 | MP0002067_abnormal_sensory_capabilities | 2.22924712 |
21 | MP0001440_abnormal_grooming_behavior | 2.14490789 |
22 | MP0009780_abnormal_chondrocyte_physiolo | 2.02579775 |
23 | MP0005423_abnormal_somatic_nervous | 2.00977654 |
24 | MP0003879_abnormal_hair_cell | 2.00521675 |
25 | MP0008569_lethality_at_weaning | 1.97807097 |
26 | MP0001970_abnormal_pain_threshold | 1.93549887 |
27 | MP0001529_abnormal_vocalization | 1.86006204 |
28 | MP0002733_abnormal_thermal_nociception | 1.84824446 |
29 | MP0003122_maternal_imprinting | 1.81414139 |
30 | MP0005386_behavior/neurological_phenoty | 1.75052959 |
31 | MP0004924_abnormal_behavior | 1.75052959 |
32 | MP0004142_abnormal_muscle_tone | 1.74091228 |
33 | MP0002557_abnormal_social/conspecific_i | 1.73774249 |
34 | MP0001984_abnormal_olfaction | 1.68751025 |
35 | MP0001188_hyperpigmentation | 1.68464768 |
36 | MP0002184_abnormal_innervation | 1.63775816 |
37 | MP0006276_abnormal_autonomic_nervous | 1.63104782 |
38 | MP0002876_abnormal_thyroid_physiology | 1.56456688 |
39 | MP0004811_abnormal_neuron_physiology | 1.50820137 |
40 | MP0001905_abnormal_dopamine_level | 1.41680505 |
41 | MP0002066_abnormal_motor_capabilities/c | 1.39722257 |
42 | MP0000920_abnormal_myelination | 1.36166958 |
43 | MP0002909_abnormal_adrenal_gland | 1.34693430 |
44 | MP0005645_abnormal_hypothalamus_physiol | 1.30610468 |
45 | MP0000778_abnormal_nervous_system | 1.29885351 |
46 | MP0004147_increased_porphyrin_level | 1.29438068 |
47 | MP0000955_abnormal_spinal_cord | 1.27579444 |
48 | MP0002882_abnormal_neuron_morphology | 1.24252227 |
49 | MP0003633_abnormal_nervous_system | 1.20544592 |
50 | MP0008872_abnormal_physiological_respon | 1.14691130 |
51 | MP0003329_amyloid_beta_deposits | 1.11577117 |
52 | MP0002837_dystrophic_cardiac_calcinosis | 1.11554447 |
53 | MP0001502_abnormal_circadian_rhythm | 1.07351081 |
54 | MP0003646_muscle_fatigue | 1.07145714 |
55 | MP0000751_myopathy | 1.06999437 |
56 | MP0004858_abnormal_nervous_system | 1.04961080 |
57 | MP0008877_abnormal_DNA_methylation | 1.03705684 |
58 | MP0003631_nervous_system_phenotype | 1.02949324 |
59 | MP0004130_abnormal_muscle_cell | 1.02907757 |
60 | MP0000013_abnormal_adipose_tissue | 1.02305473 |
61 | MP0001348_abnormal_lacrimal_gland | 0.93852038 |
62 | MP0010386_abnormal_urinary_bladder | 0.93768789 |
63 | MP0008874_decreased_physiological_sensi | 0.93657454 |
64 | MP0002069_abnormal_eating/drinking_beha | 0.93458104 |
65 | MP0001963_abnormal_hearing_physiology | 0.92217123 |
66 | MP0005167_abnormal_blood-brain_barrier | 0.91771697 |
67 | MP0002152_abnormal_brain_morphology | 0.90954200 |
68 | MP0004885_abnormal_endolymph | 0.90759315 |
69 | MP0005171_absent_coat_pigmentation | 0.90681897 |
70 | MP0002229_neurodegeneration | 0.89221285 |
71 | MP0003183_abnormal_peptide_metabolism | 0.87314474 |
72 | MP0004085_abnormal_heartbeat | 0.86785796 |
73 | MP0001986_abnormal_taste_sensitivity | 0.84937120 |
74 | MP0004043_abnormal_pH_regulation | 0.83139774 |
75 | MP0005551_abnormal_eye_electrophysiolog | 0.82751465 |
76 | MP0005394_taste/olfaction_phenotype | 0.81391011 |
77 | MP0005499_abnormal_olfactory_system | 0.81391011 |
78 | MP0004215_abnormal_myocardial_fiber | 0.81331348 |
79 | MP0001177_atelectasis | 0.81178318 |
80 | MP0001664_abnormal_digestion | 0.80345183 |
81 | MP0004484_altered_response_of | 0.80024343 |
82 | MP0004742_abnormal_vestibular_system | 0.79248880 |
83 | MP0000604_amyloidosis | 0.75504272 |
84 | MP0003283_abnormal_digestive_organ | 0.74615967 |
85 | MP0005535_abnormal_body_temperature | 0.73389620 |
86 | MP0004145_abnormal_muscle_electrophysio | 0.72725658 |
87 | MP0003121_genomic_imprinting | 0.72438798 |
88 | MP0001346_abnormal_lacrimal_gland | 0.70368310 |
89 | MP0000631_abnormal_neuroendocrine_gland | 0.68415847 |
90 | MP0003632_abnormal_nervous_system | 0.66359863 |
91 | MP0002653_abnormal_ependyma_morphology | 0.62894394 |
92 | MP0002752_abnormal_somatic_nervous | 0.62871671 |
93 | MP0003075_altered_response_to | 0.62587862 |
94 | MP0001485_abnormal_pinna_reflex | 0.60843657 |
95 | MP0003123_paternal_imprinting | 0.60084451 |
96 | MP0004233_abnormal_muscle_weight | 0.59913480 |
97 | MP0001943_abnormal_respiration | 0.55937676 |
98 | MP0006292_abnormal_olfactory_placode | 0.55809445 |
99 | MP0006035_abnormal_mitochondrial_morpho | 0.55095322 |
100 | MP0002638_abnormal_pupillary_reflex | 0.54409847 |
101 | MP0008260_abnormal_autophagy | 0.53957312 |
102 | MP0003938_abnormal_ear_development | 0.53806360 |
103 | MP0002332_abnormal_exercise_endurance | 0.53004898 |
104 | MP0010770_preweaning_lethality | 0.52591161 |
105 | MP0002082_postnatal_lethality | 0.52591161 |
106 | MP0000026_abnormal_inner_ear | 0.52315296 |
107 | MP0001765_abnormal_ion_homeostasis | 0.51817813 |
108 | MP0000569_abnormal_digit_pigmentation | 0.51651363 |
109 | MP0003137_abnormal_impulse_conducting | 0.51289987 |
110 | MP0010769_abnormal_survival | 0.51114314 |
111 | MP0003634_abnormal_glial_cell | 0.49113352 |
112 | MP0003690_abnormal_glial_cell | 0.49035626 |
113 | MP0003956_abnormal_body_size | 0.48770030 |
114 | MP0010768_mortality/aging | 0.48119340 |
115 | MP0002090_abnormal_vision | 0.46121083 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 9.25946538 |
2 | Atonic seizures (HP:0010819) | 6.53659205 |
3 | Epileptic encephalopathy (HP:0200134) | 5.93572640 |
4 | Myokymia (HP:0002411) | 5.89050922 |
5 | Febrile seizures (HP:0002373) | 5.88546277 |
6 | Focal seizures (HP:0007359) | 5.79701061 |
7 | Hyperventilation (HP:0002883) | 4.86045702 |
8 | Absence seizures (HP:0002121) | 4.81539268 |
9 | Dialeptic seizures (HP:0011146) | 4.41104433 |
10 | Progressive cerebellar ataxia (HP:0002073) | 4.34168570 |
11 | Visual hallucinations (HP:0002367) | 4.29107464 |
12 | Supranuclear gaze palsy (HP:0000605) | 4.28192540 |
13 | Generalized tonic-clonic seizures (HP:0002069) | 4.02367019 |
14 | Gaze-evoked nystagmus (HP:0000640) | 3.92683733 |
15 | Broad-based gait (HP:0002136) | 3.85816292 |
16 | Abnormal hair whorl (HP:0010721) | 3.54969123 |
17 | Mutism (HP:0002300) | 3.44563550 |
18 | Papilledema (HP:0001085) | 3.34317197 |
19 | Dysdiadochokinesis (HP:0002075) | 3.33424959 |
20 | Abnormal eating behavior (HP:0100738) | 3.31768922 |
21 | Cerebral hypomyelination (HP:0006808) | 3.31136542 |
22 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.23737217 |
23 | Dysmetric saccades (HP:0000641) | 3.15106451 |
24 | Pheochromocytoma (HP:0002666) | 3.12731675 |
25 | Neurofibrillary tangles (HP:0002185) | 3.12303724 |
26 | Poor eye contact (HP:0000817) | 3.04243805 |
27 | Action tremor (HP:0002345) | 3.01229078 |
28 | Intention tremor (HP:0002080) | 2.99952080 |
29 | Tetraplegia (HP:0002445) | 2.98419360 |
30 | Scanning speech (HP:0002168) | 2.96571562 |
31 | Truncal ataxia (HP:0002078) | 2.94525400 |
32 | Neuroendocrine neoplasm (HP:0100634) | 2.91178456 |
33 | Obstructive sleep apnea (HP:0002870) | 2.86542789 |
34 | Abnormal social behavior (HP:0012433) | 2.85061955 |
35 | Impaired social interactions (HP:0000735) | 2.85061955 |
36 | Depression (HP:0000716) | 2.80180510 |
37 | Polyphagia (HP:0002591) | 2.77553173 |
38 | Anxiety (HP:0000739) | 2.76260995 |
39 | Akinesia (HP:0002304) | 2.75663723 |
40 | Progressive inability to walk (HP:0002505) | 2.75056450 |
41 | Dysmetria (HP:0001310) | 2.73436816 |
42 | Gait imbalance (HP:0002141) | 2.72988753 |
43 | Delusions (HP:0000746) | 2.69652259 |
44 | Diplopia (HP:0000651) | 2.69002376 |
45 | Abnormality of binocular vision (HP:0011514) | 2.69002376 |
46 | Amblyopia (HP:0000646) | 2.66424437 |
47 | Epileptiform EEG discharges (HP:0011182) | 2.63597362 |
48 | Poor suck (HP:0002033) | 2.63394168 |
49 | Failure to thrive in infancy (HP:0001531) | 2.63277086 |
50 | Impaired smooth pursuit (HP:0007772) | 2.62465927 |
51 | Ventricular fibrillation (HP:0001663) | 2.61862866 |
52 | Resting tremor (HP:0002322) | 2.59388899 |
53 | Congenital primary aphakia (HP:0007707) | 2.57478119 |
54 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.56260023 |
55 | Abnormality of the corticospinal tract (HP:0002492) | 2.55670623 |
56 | Medial flaring of the eyebrow (HP:0010747) | 2.53366717 |
57 | Bundle branch block (HP:0011710) | 2.51371120 |
58 | Nephrogenic diabetes insipidus (HP:0009806) | 2.48827963 |
59 | Protruding tongue (HP:0010808) | 2.48567845 |
60 | Acute necrotizing encephalopathy (HP:0006965) | 2.48494380 |
61 | Oligomenorrhea (HP:0000876) | 2.45049905 |
62 | Lower limb muscle weakness (HP:0007340) | 2.43805337 |
63 | Fetal akinesia sequence (HP:0001989) | 2.42877088 |
64 | Status epilepticus (HP:0002133) | 2.42192180 |
65 | Cerebral inclusion bodies (HP:0100314) | 2.41789428 |
66 | Inability to walk (HP:0002540) | 2.40755316 |
67 | Impaired vibratory sensation (HP:0002495) | 2.40248278 |
68 | Drooling (HP:0002307) | 2.38305478 |
69 | Excessive salivation (HP:0003781) | 2.38305478 |
70 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.36980856 |
71 | Blue irides (HP:0000635) | 2.32809619 |
72 | Clonus (HP:0002169) | 2.32094905 |
73 | EEG with generalized epileptiform discharges (HP:0011198) | 2.30230102 |
74 | Genetic anticipation (HP:0003743) | 2.29199819 |
75 | Neuronal loss in central nervous system (HP:0002529) | 2.28496619 |
76 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.27876969 |
77 | Bradykinesia (HP:0002067) | 2.27552544 |
78 | Ankle clonus (HP:0011448) | 2.26864273 |
79 | Abnormality of the lower motor neuron (HP:0002366) | 2.26008414 |
80 | Abnormality of the labia minora (HP:0012880) | 2.24123869 |
81 | Progressive macrocephaly (HP:0004481) | 2.23991016 |
82 | Postural instability (HP:0002172) | 2.20366746 |
83 | Specific learning disability (HP:0001328) | 2.19104016 |
84 | Spastic tetraparesis (HP:0001285) | 2.18489329 |
85 | Hypsarrhythmia (HP:0002521) | 2.16028669 |
86 | Absent speech (HP:0001344) | 2.15251027 |
87 | Limb dystonia (HP:0002451) | 2.14895763 |
88 | Hemiplegia (HP:0002301) | 2.14525052 |
89 | Rigidity (HP:0002063) | 2.14334505 |
90 | Annular pancreas (HP:0001734) | 2.11120057 |
91 | Narrow nasal bridge (HP:0000446) | 2.10734573 |
92 | Focal dystonia (HP:0004373) | 2.10704284 |
93 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.10197846 |
94 | Heart block (HP:0012722) | 2.08224644 |
95 | Torticollis (HP:0000473) | 2.07976982 |
96 | Choreoathetosis (HP:0001266) | 2.04806711 |
97 | CNS hypomyelination (HP:0003429) | 2.04574166 |
98 | Prolonged QT interval (HP:0001657) | 2.04248215 |
99 | Stereotypic behavior (HP:0000733) | 2.01942035 |
100 | Hemiparesis (HP:0001269) | 2.01000959 |
101 | Gait ataxia (HP:0002066) | 2.00389261 |
102 | Syncope (HP:0001279) | 1.99977847 |
103 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.98205584 |
104 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.98205584 |
105 | Incomplete penetrance (HP:0003829) | 1.98198784 |
106 | Poor coordination (HP:0002370) | 1.97792266 |
107 | Generalized myoclonic seizures (HP:0002123) | 1.97540711 |
108 | Mitochondrial inheritance (HP:0001427) | 1.96303819 |
109 | Abnormal EKG (HP:0003115) | 1.94653334 |
110 | Abnormality of saccadic eye movements (HP:0000570) | 1.93746842 |
111 | Hyperthyroidism (HP:0000836) | 1.93676844 |
112 | Sleep apnea (HP:0010535) | 1.93559655 |
113 | Sensory axonal neuropathy (HP:0003390) | 1.93263757 |
114 | Generalized hypotonia (HP:0001290) | 1.91890038 |
115 | Esotropia (HP:0000565) | 1.90905735 |
116 | Spinal canal stenosis (HP:0003416) | 1.90373383 |
117 | Hypoventilation (HP:0002791) | 1.89502082 |
118 | Urinary urgency (HP:0000012) | 1.89427593 |
119 | Apathy (HP:0000741) | 1.88726567 |
120 | Spastic gait (HP:0002064) | 1.88712498 |
121 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.88700282 |
122 | Peripheral hypomyelination (HP:0007182) | 1.88675990 |
123 | Increased circulating renin level (HP:0000848) | 1.88541105 |
124 | Genital tract atresia (HP:0001827) | 1.87274039 |
125 | Vaginal atresia (HP:0000148) | 1.86738721 |
126 | Rapidly progressive (HP:0003678) | 1.86084688 |
127 | Confusion (HP:0001289) | 1.85671410 |
128 | Craniofacial dystonia (HP:0012179) | 1.83383379 |
129 | Hepatocellular necrosis (HP:0001404) | 1.83021102 |
130 | Limb ataxia (HP:0002070) | 1.81131334 |
131 | Acute encephalopathy (HP:0006846) | 1.80802335 |
132 | Impaired pain sensation (HP:0007328) | 1.79286601 |
133 | Abnormality of pain sensation (HP:0010832) | 1.79286601 |
134 | Abnormal atrioventricular conduction (HP:0005150) | 1.79116320 |
135 | Megalencephaly (HP:0001355) | 1.75496180 |
136 | Dyskinesia (HP:0100660) | 1.73171545 |
137 | Insomnia (HP:0100785) | 1.67034301 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CASK | 5.62382515 |
2 | NTRK3 | 4.00597796 |
3 | EPHA4 | 3.61456734 |
4 | MAP3K12 | 3.43664225 |
5 | MAP2K7 | 3.30044148 |
6 | MAP3K4 | 3.14401489 |
7 | CDK19 | 2.79405420 |
8 | DAPK2 | 2.53687897 |
9 | PRPF4B | 2.31400598 |
10 | MAP3K9 | 2.24733252 |
11 | DAPK1 | 2.20584489 |
12 | AKT3 | 2.19668127 |
13 | MINK1 | 2.17000285 |
14 | PLK2 | 2.09321577 |
15 | MAP2K4 | 1.95989313 |
16 | SIK3 | 1.81664573 |
17 | TSSK6 | 1.79980662 |
18 | CCNB1 | 1.69714213 |
19 | RIPK4 | 1.64007442 |
20 | NTRK2 | 1.62793328 |
21 | TNIK | 1.60626914 |
22 | OXSR1 | 1.54168512 |
23 | SGK2 | 1.47888454 |
24 | CAMKK2 | 1.45399880 |
25 | GRK5 | 1.42309096 |
26 | MARK1 | 1.37174398 |
27 | PRKCG | 1.35028725 |
28 | SGK223 | 1.32199253 |
29 | SGK494 | 1.32199253 |
30 | CAMKK1 | 1.29099981 |
31 | LATS2 | 1.28957701 |
32 | ARAF | 1.26206874 |
33 | RIPK1 | 1.25581121 |
34 | CDK5 | 1.24093201 |
35 | PDK4 | 1.19606992 |
36 | PDK3 | 1.19606992 |
37 | TYRO3 | 1.18183778 |
38 | KSR1 | 1.17570772 |
39 | MAPK13 | 1.16748938 |
40 | PAK3 | 1.15843526 |
41 | FES | 1.11165959 |
42 | PAK6 | 1.08598936 |
43 | CAMK2A | 1.06986679 |
44 | SGK3 | 1.01885515 |
45 | NME1 | 1.00163859 |
46 | CAMK2B | 0.96073800 |
47 | BMPR2 | 0.92654065 |
48 | BRAF | 0.90601137 |
49 | NTRK1 | 0.88732826 |
50 | PKN1 | 0.86953431 |
51 | CDK18 | 0.84228911 |
52 | MAPK12 | 0.84186217 |
53 | KSR2 | 0.81180058 |
54 | STK38 | 0.80017116 |
55 | PTK2B | 0.79366788 |
56 | CAMK1 | 0.77505029 |
57 | TNK2 | 0.77254907 |
58 | ALK | 0.74770632 |
59 | LIMK1 | 0.74460131 |
60 | BCR | 0.74064563 |
61 | MARK2 | 0.74003493 |
62 | PRKCE | 0.73836299 |
63 | CDK15 | 0.73641422 |
64 | PRKD3 | 0.72127804 |
65 | CDK14 | 0.70612151 |
66 | PDK2 | 0.68734245 |
67 | PRKCH | 0.68090012 |
68 | SGK1 | 0.67532647 |
69 | PINK1 | 0.64796043 |
70 | ADRBK2 | 0.64229544 |
71 | BRSK1 | 0.63954673 |
72 | FRK | 0.63586824 |
73 | NEK1 | 0.63037023 |
74 | CDK11A | 0.61888605 |
75 | UHMK1 | 0.61863614 |
76 | SIK2 | 0.61204821 |
77 | FGFR2 | 0.60929364 |
78 | DAPK3 | 0.58714737 |
79 | MAPK10 | 0.56101629 |
80 | CAMK2G | 0.55911426 |
81 | MYLK | 0.55690716 |
82 | GRK7 | 0.54112438 |
83 | STK11 | 0.53924318 |
84 | PNCK | 0.52901592 |
85 | PDK1 | 0.52644705 |
86 | CDK8 | 0.50729222 |
87 | CAMK2D | 0.49941651 |
88 | CAMK4 | 0.49107347 |
89 | DYRK1A | 0.48332827 |
90 | MAP3K13 | 0.48081646 |
91 | PRKCZ | 0.47013503 |
92 | MUSK | 0.45961057 |
93 | NEK6 | 0.45399417 |
94 | PDPK1 | 0.45245014 |
95 | ADRBK1 | 0.41776905 |
96 | CSNK1G2 | 0.41663338 |
97 | FER | 0.41424044 |
98 | WNK3 | 0.39976852 |
99 | RPS6KA3 | 0.39937391 |
100 | MAPKAPK5 | 0.38039304 |
101 | CDK3 | 0.37599356 |
102 | RAF1 | 0.37409805 |
103 | MAP2K6 | 0.37348639 |
104 | MAP3K11 | 0.37031977 |
105 | PRKACA | 0.36814877 |
106 | PRKG1 | 0.36543241 |
107 | MAP3K2 | 0.35258195 |
108 | WNK1 | 0.35170322 |
109 | MKNK2 | 0.35107715 |
110 | MAP3K1 | 0.34826999 |
111 | ERBB4 | 0.34289678 |
112 | MAPK7 | 0.33314217 |
113 | OBSCN | 0.31256733 |
114 | PRKCB | 0.30958198 |
115 | PRKCA | 0.30310744 |
116 | ROCK1 | 0.29980719 |
117 | MAP2K1 | 0.29980344 |
118 | CSNK1A1 | 0.29192908 |
119 | ROCK2 | 0.29098438 |
120 | ERBB2 | 0.28669215 |
121 | PHKG2 | 0.28027345 |
122 | PHKG1 | 0.28027345 |
123 | FYN | 0.27644104 |
124 | LMTK2 | 0.27375203 |
125 | PRKG2 | 0.27260827 |
126 | STK39 | 0.26720693 |
127 | INSRR | 0.24685977 |
128 | MAPK8 | 0.24364351 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.42736442 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.23319590 |
3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.25274104 |
4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.92241109 |
5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.86258655 |
6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.78136538 |
7 | Morphine addiction_Homo sapiens_hsa05032 | 2.77375630 |
8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.63900266 |
9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.52820321 |
10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.47900044 |
11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.42093430 |
12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.09744434 |
13 | Taste transduction_Homo sapiens_hsa04742 | 2.01923685 |
14 | Salivary secretion_Homo sapiens_hsa04970 | 2.01095074 |
15 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.97070688 |
16 | Insulin secretion_Homo sapiens_hsa04911 | 1.80516551 |
17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.79701127 |
18 | Long-term depression_Homo sapiens_hsa04730 | 1.73208951 |
19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.68771232 |
20 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.65351367 |
21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.62760692 |
22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.61198918 |
23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.60115575 |
24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.56267970 |
25 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.55889218 |
26 | Renin secretion_Homo sapiens_hsa04924 | 1.55299771 |
27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.53315129 |
28 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.51571315 |
29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.50405954 |
30 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.46422983 |
31 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.43126040 |
32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.37350430 |
33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.29893319 |
34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.21142774 |
35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.14797288 |
36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.12153858 |
37 | Gap junction_Homo sapiens_hsa04540 | 1.10232128 |
38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.06616206 |
39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03201124 |
40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.01542188 |
41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.01474125 |
42 | Parkinsons disease_Homo sapiens_hsa05012 | 1.01240751 |
43 | Alzheimers disease_Homo sapiens_hsa05010 | 0.98913192 |
44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.97765732 |
45 | Phototransduction_Homo sapiens_hsa04744 | 0.97513299 |
46 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.92987091 |
47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.92056653 |
48 | Bile secretion_Homo sapiens_hsa04976 | 0.88919290 |
49 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.88613052 |
50 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.84262335 |
51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.82216984 |
52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.80651752 |
53 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.78488002 |
54 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77927093 |
55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77663240 |
56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76485568 |
57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.71268729 |
58 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.71086139 |
59 | Melanogenesis_Homo sapiens_hsa04916 | 0.70269629 |
60 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68345451 |
61 | Glioma_Homo sapiens_hsa05214 | 0.68169601 |
62 | Axon guidance_Homo sapiens_hsa04360 | 0.68064249 |
63 | Huntingtons disease_Homo sapiens_hsa05016 | 0.63651782 |
64 | Phagosome_Homo sapiens_hsa04145 | 0.62550411 |
65 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.59916300 |
66 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.59731621 |
67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.59186196 |
68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56193180 |
69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55753298 |
70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54279238 |
71 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.53568708 |
72 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.53463913 |
73 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.52070784 |
74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.51982190 |
75 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49763858 |
76 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46012366 |
77 | Alcoholism_Homo sapiens_hsa05034 | 0.43982046 |
78 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42596440 |
79 | Mineral absorption_Homo sapiens_hsa04978 | 0.41321194 |
80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40544870 |
81 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.39930046 |
82 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39647076 |
83 | Prion diseases_Homo sapiens_hsa05020 | 0.39542541 |
84 | Histidine metabolism_Homo sapiens_hsa00340 | 0.39076220 |
85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38207854 |
86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38138385 |
87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34940166 |
88 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34077695 |
89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33587558 |
90 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32556971 |
91 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.31548873 |
92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.28078445 |
93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.27506715 |
94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.26271681 |
95 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.24525700 |
96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.24462066 |
97 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.23606318 |
98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.22849384 |
99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.22641111 |
100 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.22530423 |
101 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.22342506 |
102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.22290425 |
103 | Melanoma_Homo sapiens_hsa05218 | 0.21531448 |
104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.20624467 |
105 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.19702488 |
106 | Endocytosis_Homo sapiens_hsa04144 | 0.19304710 |
107 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.19072839 |
108 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.18696890 |
109 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.18684316 |
110 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.18001882 |
111 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.17884668 |
112 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.17677579 |
113 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.17630490 |
114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.16695033 |
115 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.16520613 |
116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.15699290 |